USSTOCK.TODAY
After-Market
Log in Sign up

BioMarin Q3 Earnings Release: A Test of the Gap Between Business Performance and Stock Price

Earnings Whispers · ·by G4L

BMRN
BMRN Biomarin Pharmaceutical Inc
$57.13 -0.09%
View chart & analysis →
  1. 1BioMarin will release its third-quarter earnings on November 2.
  2. 2Analysts expect third-quarter revenue to be approximately $1.03 billion.
  3. 3BioMarin's stock price recorded 13.7%, falling more than 12 percentage points behind the S&P 500 return.

So what's the key point?

BioMarin is announcing its third-quarter results on November 2. Experts expect revenue to be around $1.03 billion, but the stock price has fallen significantly compared to the market.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Grifols beats expectations with 2.04 billion euro third-quarter revenue Nasdaq +1 · Nov 3BioMarin Pharma Exceeds $1 billion in Quarterly Revenue for the First Time The Motley Fool +1 · Nov 3Sprout Social beats 2Q adjusted EPS estimate at 26 cents Associated Press +1 · Aug 7
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news